A
ARDX
Ardelyx
6.10
+0.15+2.52%After Hours: 6.15 +0.05 +0.82%19:59 04/08 EDT
OPEN/PREV CLOSE6.12/5.95
TODAY RANGE6.05-6.22
VOL3.05M
MARKET CAP1.50B
52 WEEK RANGE3.210-8.40
AVG VOL (3M)4.07M
% TURNOVER1.24%
TURNOVER--
P/E (TTM)-23.8654
% RANGE2.86%
EPS(TTM)-0.2556
P/E(FORWARD)203.33
P/B8.93
BVPS0.6832
DIVIDEND--
P/S3.659
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.44B
SHARES OUTSTANDING245.25M
NEXT EARNINGS04/29-05/04
FREE FLOAT236.33M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·04/01 12:01
RAJANI DINAVAHI, MD, APPOINTED CHIEF MEDICAL OFFICER OF ARDELYX
Dow Jones·04/01 12:01
Press Release: Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
Dow Jones·04/01 12:01
*Ardelyx Appoints Rajani Dinavahi Chief Medical Officer >ARDX
TipRanks·03/05 13:09
Zevra Therapeutics appoints Renz as Chief Financial Officer
Reuters·03/05 12:31
Zevra Therapeutics Names Justin Renz Chief Financial Officer
Reuters·03/04 13:02
Ardelyx to Present at Leerink Partners 2026 Global Healthcare Conference
Reuters·02/25 21:13
Ardelyx President and CEO Michael Raab Disposes of Common Shares
NASDAQ·02/24 15:32
Tuesday 2/24 Insider Buying Report: ARDX, LPX
Seeking Alpha·02/24 14:20
Ardelyx gains after marketing deal with LPGA
TipRanks·02/24 13:18
Ardelyx, LPGA announce multi-year partnership
Reuters·02/24 13:02
Ardelyx inks multi-year partnership with LPGA Tour
Same Industry
Name/Symbol
Change%
Price